UPLOAD Filing
Tevogen Bio Holdings Inc.
Date: June 24, 2025 · CIK: 0001860871 · Accession: 0000000000-25-006572
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288218
Letter
Re: Tevogen Bio Holdings Inc. Registration Statement on Form S-3 Filed June 20, 2025 File No. 333-288218 Dear Ryan Saadi:
June 24, 2025
Ryan Saadi Chief Executive Officer Tevogen Bio Holdings Inc. 15 Independence Boulevard, Suite #210 Warren, NJ 07059
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Daniel Crawford at 202-551-7767 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: William Intner, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> June 24, 2025 Ryan Saadi Chief Executive Officer Tevogen Bio Holdings Inc. 15 Independence Boulevard, Suite #210 Warren, NJ 07059 Re: Tevogen Bio Holdings Inc. Registration Statement on Form S-3 Filed June 20, 2025 File No. 333-288218 Dear Ryan Saadi: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: William Intner, Esq. </TEXT> </DOCUMENT>